Actinium Pharmaceuticals, Inc. (ATNM) vs Celularity, Inc. (CELU)
Actinium Pharmaceuticals, Inc. and Celularity, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Celularity, Inc. are of similar size ($38.2M and $37.4M). Celularity, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.3×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against −51.0%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs −345.8%) and the higher return on invested capital (0.00% vs −1,070.9%). Across the 16 metrics below, Actinium Pharmaceuticals, Inc. leads on 11 and Celularity, Inc. on 5.
Valuation
Profitability
| Metric | ATNM | CELU | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 24.39% | 65.16% |
| Operating margin | 27.20% | (230.92%) | 0.00% |
| Net margin | 32.18% | (345.76%) | 0.00% |
| Free cash flow margin | (66.16%) | (49.92%) | 0.00% |
| Return on equity | 45.86% | 628.23% | (57.72%) |
| Return on assets | 21.92% | (76.50%) | (49.22%) |
| Return on invested capital | 0.00% | (1,070.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack